November 28, 2025 Old Drug, New Life: Colchicine Cuts Cardiovascular Risk September 11, 2025 Novartis Strengthens Cardiovascular Portfolio: Acquires Tourmaline Bio, Strikes $1.4 Billion Deal Novartis Strengthens Cardiovascular Portfolio: Acquires Tourmaline Bio, Strikes $1.4 Billion… Read more 2/2